INTRODUCTION AND OBJECTIVES: Penile cancer (PeC) is a rare disease with high morbidity and mortality. Few studies have investigated miRNAs and their role in regulating gene networks and signaling pathways in PeC. Therefore, we aimed to identify a molecular signature based on miRNA and gene expression profiling related to carcinogenesis and prognosis in order to describe new biomarkers in PeC.
METHODS: We prospectively collected fresh samples of primary tumors (TT) and adjacent non-neoplastic tissue (NT) from 11 patients who underwent surgical treatment. 5 patients had localized disease (non-metastatic group) and 6 had inguinal lymph node metastases (metastatic group). RNA was purified and microarray analysis was performed using miRNA 4.0 Genechip (Affymetrix). We identified the differentially expressed miRNAs (DEmiRs) comparing TT of metastatic to non-metastatic patients and the DEmiRs comparing TT to NT of the 11 patients using TAC Software. The DEmiRs expression were validated in an expanded sample of 24 patients by qRT-PCR using TaqMan assays. The DEmiRs predicted targets of both comparisons were investigated using miRTarBase, mirWalk and MetaCore softwares. We evaluated these target transcripts expression using a high-throughput nanofluidic qRT-PCR platform. We correlated the DEmiR and mRNA expression to the classic prognostic factors and cancer specific survival.
RESULTS: The mean follow-up time was 16.3 months. Half of patients developed metastasis to inguinal nodes and 7 have died of the disease. We identified and validated 8 DEmiRs (miR31-5p, miR31-3p, miR224-5p, miR200a-5p, miR432-5p, miR487b-3p, miR30a-5p, miR149-5p) and 35 differentially expressed genes (DEGs) when comparing TT vs NT. We validated the DEmiRs miR421 and miR744-5p and 7 DEGs (CCND1, EGFR, ENTPD5, HOXA10, IGF1R, MYC, SNAI2) at the metastatic vs non-metastatic comparison. The miR31-3p down expression was associated with metastasis (p[0.043) CONCLUSIONS: We described a miRNA and mRNA expression profile associated to carcinogenesis and worst prognosis of penile cancer. We postulated that miR31-5p, MMP1, CCND1, EGFR, MYC, MMP9 and SNAI2 expressions are potential biomarkers for prognosis in PeC. INTRODUCTION AND OBJECTIVES: Short of surgical extirpation, ureteropyeloscopy with endoscopic biopsy remains the standard for establishing a histologic diagnosis of upper tract urothelial carcinoma (UTUC). Endoscopic biopsy is safe and affords visualization; however, it is not always feasible, and its diagnostic accuracy is debated. We report our experience with percutaneous image-guided core-needle biopsy (CNB) for UTUC to better understand safety and diagnostic accuracy.
METHODS: We retrospectively reviewed 444 patients undergoing radical nephroureterectomy (RNU) for UTUC at Mayo Clinic between 2009 and 2017. Forty-two patients undergoing CNB prior to RNU Vol. 201, No. 4S, Supplement, Sunday, May 5, 2019 THE JOURNAL OF UROLOGY Ò e713
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